Literature DB >> 22202202

Liquid antisolvent precipitation process for solubility modulation of bicalutamide.

Tarique Ali Meer1, Kiran P Sawant, Purnima D Amin.   

Abstract

Liquid antisolvent process was explored as a solubility modulating tool. Bicalutamide, a poorly water soluble drug, was used as a candidate. Low aqueous solubility and poor dissolution of bicalutamide results into poor and variable bioavailability. Therefore, the objective of the present work was to modify the solubility of bicalutamide using the liquid antisolvent precipitation process. HPMC E5 and Poloxamer 407 were shortlisted as a hydrophilic polymer and surfactant, respectively, for the process. Process optimization was done with respect to the hydrophilic polymer, surfactant and drug loading concentration. The resultant microcrystals were characterized with various instrumental techniques for material characterization such as IR, DSC, SEM, XRD, particle size, specific surface area and dissolution kinetics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22202202     DOI: 10.2478/v10007-011-0036-0

Source DB:  PubMed          Journal:  Acta Pharm        ISSN: 1330-0075            Impact factor:   2.230


  3 in total

Review 1.  Liquid antisolvent crystallization of pharmaceutical compounds: current status and future perspectives.

Authors:  Rahul Kumar; Amit K Thakur; Nilanjana Banerjee; Ashutosh Kumar; Gajendra Kumar Gaurav; Raj Kumar Arya
Journal:  Drug Deliv Transl Res       Date:  2022-08-11       Impact factor: 5.671

2.  Porous starch: a novel carrier for solubility enhancement of carbamazepine.

Authors:  Meer Tarique Ali; Ritesh Fule; Ajay Sav; Purnima Amin
Journal:  AAPS PharmSciTech       Date:  2013-05-29       Impact factor: 3.246

3.  Impact of Excipients and Seeding on the Solid-State Form Transformation of Indomethacin during Liquid Antisolvent Precipitation.

Authors:  Mariana Hugo Silva; Ajay Kumar; Benjamin K Hodnett; Lidia Tajber; René Holm; Sarah P Hudson
Journal:  Cryst Growth Des       Date:  2022-09-09       Impact factor: 4.010

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.